PROM1 and lung carcinoma: Zhang et al. used a combination of SLM- and gefitinib-loaded NPs, synthesized separately by an emulsion-solvent evaporation approach, to selectively eliminate CD133+ CSCs in the spheroids of CD133+ lung cancer cells in vitro and in a xenograft mouse model inoculated with CD133+ lung tumor cells [45].